• No results found

Extended-spectrum beta-lactamase producing Enterobacteriaceae:

N/A
N/A
Protected

Academic year: 2021

Share "Extended-spectrum beta-lactamase producing Enterobacteriaceae:"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Extended-spectrum beta-lactamase

producing Enterobacteriaceae:

aspects on detection, epidemiology and multi-drug resistance

Maria Tärnberg

Linköping University medical dissertations, No. 1300

Linköping University medical dissertations, No. 1300 Klinisk mikrobiologi,

Institutionen för klinisk och experimentell medicin, Linköpings Universitet , 581 85 Linköping M ar ia T är nb erg Ex tend ed -sp ec tru m b eta -la cta m as e p rod uc ing E nte rob ac ter iac eae : a sp ec ts o n d ete ctio n, e pid em iolo gy a nd m ult i-d ru g re sis tan ce

2

012

References

Related documents

The ability to differentiate isolates with high resolution methods is essential in order to define the strains that are transmitted in a local outbreak from those strains occurring

In this study we determined resistance profiles and genotypes of ESBL-producing bacteria in randomly selected Escherichia coli from Franklin´s gulls (Leucophaeus pipixcan) at

Recurrent urinary tract infections with ESBL-producing Escherichia coli are caused by isolates of specific phylotypes and clones...

In this study, results for the initial detection of ESBLs using the CLSI breakpoints for susceptibility show that isolates which demonstrated susceptibility to the third

Vid utodling på CHROMagar™ mSuperCARBA™ observerades växt av samtliga stammar som producerade ESBL CARBA och isolat från CPE-studie

Anna Fagerström (2020): Long-term molecular epidemiology of extended- spectrum β-lactamase-producing Escherichia coli in a low-endemic setting.. Örebro Studies in

A majority of the isolates were multiresistant and a significant difference in susceptibility between CTX-M groups, in favor of group 9 over group 1, was seen for many of

A clinical approach to faecal carriage may be screening of immunocompromised patients, such as patients with haematological and oncological malignancies as well as transplant